Real-time multi-modality imaging of glioblastoma tumor resection and recurrence

Journal of Neuro-Oncology

Volumn 111, Issue 2, 2013, Pages 153-161

  Hingtgen, Shawn ^a   Figueiredo, Jose Luiz ^a   Farrar, Christian ^a   Duebgen, Matthias ^a   Martinez Quintanilla, Jordi ^a   Bhere, Deepak ^a   Shah, Khalid ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Glioma; Image Guided resection; In vivo imaging; Recurrence

Indexed keywords

AMINOLEVULINIC ACID; PORPHYRIN; CD31 ANTIGEN; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FLUORESCENCE IMAGING; GLIOBLASTOMA; GUIDED IMAGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LONGITUDINAL STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REAL TIME ULTRASOUND SCANNER; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR GROWTH; ANALYSIS OF VARIANCE; ANIMAL; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; LUMINESCENCE; METABOLISM; NUDE MOUSE; TIME; TUMOR CELL LINE; TUMOR RECURRENCE; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD31; BRAIN NEOPLASMS; CELL LINE, TUMOR; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; KI-67 ANTIGEN; LUMINESCENT MEASUREMENTS; MICE; MICE, NUDE; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 84879300244     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-1008-z     Document Type: Article

References (30)

1. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061-1083
2. Asthagiri AR, Pouratian N, Sherman J, Ahmed G, Shaffrey ME (2007) Advances in brain tumor surgery. Neurol Clin 25(4):975-1003 Viii-ix
3. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198
4. Stark AM, Nabavi A, Mehdorn HM, Blomer U (2005) Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg Neurol 63(2):162-169 discussion 169
5. Fomchenko EI, Holland EC (2006) Mouse models of brain tumors and their applications in preclinical trials. Clin Cancer Res 12:5288-5297
6. Jacobs VL, Valdes PA, Hickey WF, De Leo JA (2011) Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro 3:e00063
7. Dai C, Holland EC (2001) Glioma models. Biochim Biophys Acta 1551:M19-M27
8. Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7:283-289
9. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401
10. Quant EC, Wen PY (2011) Response assessment in neuro-oncology. Curr Oncol Rep 13:50-56
11. Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH (2011) Monitoring radiographic brain tumor progression. Toxins (Basel) 3:191-200
12. Akbar U, Jones T, Winestone J, Michael M, Shukla A, Sun Y, Duntsch C (2009) Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. J Neurooncol 94:203-212
13. Kauer TM, Figueiredo JL, Hingtgen S, Shah K (2011) Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 15(2):197-204
14. Bello L, Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Tomei G, Villani R, Scaglione F, Carroll RS, Bikfalvi A (2002) Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors. Clin Cancer Res 8:3539-3548
15. Shah K, Hingtgen S, Kasmieh R, Figueiredo JL, Garcia-Garcia E, Martinez-Serrano A, Breakefield X, Weissleder R (2008) Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci 28:4406-4413
16. Nieder C, Grosu AL, Molls M (2000) A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 26:397-409
17. Hou LC, Veeravagu A, Hsu AR, Tse VC (2006) Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 20:E5
18. Hillier WF Jr (1954) Total left cerebral hemispherectomy for malignant glioma. Neurology 4:718-721
19. Kanaly CW, Ding D, Mehta AI, Waller AF, Crocker I, Desjardins A, Reardon DA, Friedman AH, Bigner DD, Sampson JH (2011) A novel method for volumetric MRI response assessment of enhancing brain tumors. PLoS One 6:e16031
20. Nazzaro JM, Neuwelt EA (1990) The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344
21. Quigley, Maroon JC (1991) The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29(3):385-388 discussion 388-389
22. Hess KR (1999) Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227-231
23. Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev (3):CD002034
24. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J, Reulen HJ (1998) In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45:160-169
25. Hingtgen SD, Kasmieh R, van de Water J, Weissleder R, Shah K (2010) A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. Stem Cells 28:832-841
26. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591-607
27. Heckl S, Pipkorn R, Nagele T, Vogel U, Kuker W, Voight K (2004) Molecular imaging: bridging the gap between neuroradiology and neurohistology. Histol Histopathol 19:651-668
28. Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD (2009) Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 69(8):3472-3481
29. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7:164-176
30. Taghva A, Khalessi AA, Kim PE, Liu CY, Apuzzo ML (2010) From atom to brain: applications of molecular imaging to neurosurgery. World Neurosurg 73:477-485